Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06538610
NA
The 5-FU Holter Study
Sponsor: University of Auckland, New Zealand
View on ClinicalTrials.gov
Summary
To assess the feasibility of using ambulatory ECG monitoring (Holter monitor) for patients receiving 5-FU chemotherapy
Official title: Feasibility Study of Ambulatory Holter Monitoring While Receiving Infusional Fluorouracil (5-FU) Chemotherapy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2024-11-01
Completion Date
2026-01
Last Updated
2024-12-09
Healthy Volunteers
No
Conditions
Interventions
DEVICE
Holter monitor
Holter monitor fitted from start of 5-FU infusion (Day 1) to 5-FU infusion ending (Day 3). Holter monitor to be worn for approximately 46-48 hours.
Locations (1)
Auckland City Hospital
Auckland, New Zealand